European Pension Funds and Endowments Rekindle Interest in Private Equity Investments in China
ByAinvest
Wednesday, Oct 1, 2025 6:13 pm ET2min read
CG--
The renewed interest in China is driven by several factors. Firstly, the Chinese market is booming due to optimism over technology breakthroughs and economic growth. Secondly, there is a shift away from the US, partly due to President Donald Trump's tariff policies, which have stoked interest in China. Additionally, some investors expect the US to roll back its outbound investment curbs, further encouraging investment in China [1].
Despite the increased interest, China's climb back to its previous prominence in private equity will be steep. Global investors have sharply reduced their allocations to China, dragging down Asia's share of private equity fundraising to multi-year lows. In 2024, Asia made up just 7% of global PE fundraising, compared to 13% in 2021 [1]. Furthermore, China's share of Asia-Pacific deal value fell to just 27% in 2024, down from more than half in 2020 [1].
The private equity industry has reassessed China, with larger firms pausing or pulling back from deals since 2022. Larger PE firms participated in just 6% of the deal value in China last year, down from an average of 24% between 2018 and 2023 [1]. While North American investors remain largely against investing in China, certain European investors, particularly in Scandinavia, are also hesitant due to concerns over supporting Russia's war effort [1].
Recent months have shown signs of increased private equity dealmaking in China. In August, TPG and the Qatar Investment Authority offered to buy out Hong Kong-listed Kangji Medical Holdings Ltd. in a deal valuing the Chinese medical device maker at about $1.4 billion. Meanwhile, KKR & Co. is nearing the acquisition of an 85% stake in Chinese soda maker Dayao Beverage, valued at around $1 billion [1].
Vishal Mahadevia, head of Asia private equity at Warburg Pincus, believes now is a good time to get back into China. "It's the second-largest economy in the world and it would be smart to have a presence there to build a diversified global portfolio," he said in a recent interview [1]. However, capital deployment will remain limited until investors see a series of sizable investments and exits in China, serving as critical signals that the market has truly returned.
In conclusion, European pension funds and endowments are re-evaluating their investment strategies in China. While the market presents opportunities, it also comes with significant risks and uncertainties. Investors should carefully consider these factors before making any investment decisions.
European pension funds and endowments are re-exploring private equity investments in China after years of shunning the country. Firms such as Carlyle Group, Warburg Pincus, and PAG are fielding inquiries from global investors. However, China's climb back to prominence in private equity will be steep, given reduced allocations to the country and a decline in Asia's share of private equity fundraising to multi-year lows.
European pension funds and endowments are once again exploring private equity investments in China after years of shunning the country. Firms such as Carlyle Group, Warburg Pincus, and PAG are fielding inquiries from global investors, according to people familiar with the matter [1]. This shift is a stark contrast to the past few years when political tensions and China's crackdown on private enterprise led to a decline in investment.The renewed interest in China is driven by several factors. Firstly, the Chinese market is booming due to optimism over technology breakthroughs and economic growth. Secondly, there is a shift away from the US, partly due to President Donald Trump's tariff policies, which have stoked interest in China. Additionally, some investors expect the US to roll back its outbound investment curbs, further encouraging investment in China [1].
Despite the increased interest, China's climb back to its previous prominence in private equity will be steep. Global investors have sharply reduced their allocations to China, dragging down Asia's share of private equity fundraising to multi-year lows. In 2024, Asia made up just 7% of global PE fundraising, compared to 13% in 2021 [1]. Furthermore, China's share of Asia-Pacific deal value fell to just 27% in 2024, down from more than half in 2020 [1].
The private equity industry has reassessed China, with larger firms pausing or pulling back from deals since 2022. Larger PE firms participated in just 6% of the deal value in China last year, down from an average of 24% between 2018 and 2023 [1]. While North American investors remain largely against investing in China, certain European investors, particularly in Scandinavia, are also hesitant due to concerns over supporting Russia's war effort [1].
Recent months have shown signs of increased private equity dealmaking in China. In August, TPG and the Qatar Investment Authority offered to buy out Hong Kong-listed Kangji Medical Holdings Ltd. in a deal valuing the Chinese medical device maker at about $1.4 billion. Meanwhile, KKR & Co. is nearing the acquisition of an 85% stake in Chinese soda maker Dayao Beverage, valued at around $1 billion [1].
Vishal Mahadevia, head of Asia private equity at Warburg Pincus, believes now is a good time to get back into China. "It's the second-largest economy in the world and it would be smart to have a presence there to build a diversified global portfolio," he said in a recent interview [1]. However, capital deployment will remain limited until investors see a series of sizable investments and exits in China, serving as critical signals that the market has truly returned.
In conclusion, European pension funds and endowments are re-evaluating their investment strategies in China. While the market presents opportunities, it also comes with significant risks and uncertainties. Investors should carefully consider these factors before making any investment decisions.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet